Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies

SIMPLE SUMMARY: Novel treatments in immunotherapy for gynecologic oncology have not successfully developed from preclinical research to clinical trials. Preclinical models used to investigate immunotherapy agents are summarized in order to enhance understanding of the inherent limitations and areas...

Descripción completa

Detalles Bibliográficos
Autores principales: Dholakia, Jhalak, Scalise, Carly, Arend, Rebecca C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038292/
https://www.ncbi.nlm.nih.gov/pubmed/33918476
http://dx.doi.org/10.3390/cancers13071694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038292/
https://www.ncbi.nlm.nih.gov/pubmed/33918476
http://dx.doi.org/10.3390/cancers13071694

Ejemplares similares